CoLucid Pharmaceuticals granted Ildong Pharmaceutical exclusive rights to develop and commercialize lasmiditan in South Korea and Southeast Asia

CoLucid Pharmaceuticals Inc.

U.S. / Private Biopharma

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Ildong Pharmaceutical Co. Ltd.

South Korea / Small-Cap Biopharma (<$1 billion)

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced